In addition, the human epidermal growth factor receptor 2 (HER2) was negative, ki67 was 40%, MSS, Epstein‐Barr virus-encoded small RNA (EBER) negative, programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) < 1%, combined positive score (CPS) < 1%, low tumor mutational burden (TMB-L), with MET amplification (7) (Fig. 1). This evidence concerns the gene MET and neoplasm.